Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients

Srilakshmi Vallabhaneni, Kathleen W. Zhang, Jose A. Alvarez-Cardona, Joshua D. Mitchell, Henning Steen, Pamela K. Woodard, Daniel J. Lenihan

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

The purpose of this review is to provide an overview of the essential role that cardiovascular magnetic resonance (CMR) has in the field of cardio-oncology. Recent findings: CMR has been increasingly used for early identification of cancer therapy related cardiac dysfunction (CTRCD) due to its precision in detecting subtle changes in cardiac function and for myocardial tissue characterization. Summary: CMR is able to identify subclinical CTRCD in patients receiving potentially cardiotoxic chemotherapy and guide initiation of cardio protective therapy. Multiparametric analysis with myocardial strain, tissue characterization play a critical role in understanding important clinical questions in cardio-oncology.

Original languageEnglish
Pages (from-to)3003-3017
Number of pages15
JournalInternational Journal of Cardiovascular Imaging
Volume37
Issue number10
DOIs
StatePublished - Oct 2021

Keywords

  • CMR
  • Cancer therapy related cardiac dysfunction (CTRCD)
  • Cardio-oncology
  • Imaging

Fingerprint

Dive into the research topics of 'Role of cardiovascular magnetic resonance in early detection and treatment of cardiac dysfunction in oncology patients'. Together they form a unique fingerprint.

Cite this